← FDA Drug Approvals (Drugs@FDA)

EBANGA

BLA · Biologics License Application · Sponsor: RIDGEBACK BIOTHERAPEUTICS · Approved 2020-12-21

Drug application

FDA Application #

BLA761172

Application type

Biologics License Application

Brand name

EBANGA

Generic name

ANSUVIMAB

Active ingredients

ANSUVIMAB-ZYKL

Dosage form

POWDER

Route

IV (INFUSION)

Marketing status

Prescription

Sponsor

RIDGEBACK BIOTHERAPEUTICS

Manufacturer

Emergent Manufacturing Operations Baltimore, LLC

First approval

2020-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown